Substrate
financeSourced

Workiva Names New Director Following Shareholder Meeting

Workiva Inc. elected a new board member and accepted the departure of an existing director at its annual shareholder meeting. The changes alter the company's board composition and trigger standard SEC disclosure and governance processes for public companies.

SEC EDGAR — WORKIVA INC (WK)
1 source·Jun 1, 8:00 PM·1m read
Workiva Names New Director Following Shareholder Meetinginsidermonkey.com
Audio version
Tap play to generate a narrated version.

Workiva Inc. (NYSE: WK) reported the election of one new director and the departure of another at its 2026 annual meeting of shareholders, according to an 8-K filed with the SEC on June 2, 2026.

The filing discloses results under Item 5.07 for the submission of matters to a vote of security holders and details a board change under Item 5.02. One director whose term ended did not stand for re-election and therefore departed the board effective at the meeting on June 2, 2026. The company simultaneously elected a named successor to fill the vacancy.

Workiva has 11 directors following the change. The new director assumes all standard board responsibilities, including service on any assigned committees. The departing director's service on any committees ends immediately.

The board transition requires Workiva to update its governance disclosures. The company must reflect the new board composition in its next proxy statement or Form 10-K, and any committee reassignments must be reported. Item 9.01 of the filing includes exhibits that document the voting results and the resignation letter or related board materials.

This marks the latest board-level change for the Iowa-based provider of financial reporting and compliance software. Public companies must file Form 8-K within four business days of director elections or departures under Items 5.02 and 5.07. Workiva's filing meets that deadline for the June 2 meeting.

The events follow standard corporate-governance timelines set by the company's bylaws and Nasdaq listing rules, which require prompt notification to shareholders of board changes that affect control, audit-committee membership or overall composition.

Coverage spread

Substrate’s article above is written from the primary record. Below: how mainstream outlets reported the same event.

No mainstream coverage of this story has surfaced yet.

Transparency

Confidence90%

Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.

Related Stories

U.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effectthehindu.com
finance44 min ago

U.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effect

A U.S. aircraft fired an AGM-114 Hellfire missile into the engine room of the M/T Lexie on Tuesday, disabling the unladen vessel as it headed toward Kharg Island. The strike followed repeated ignored warnings over 24 hours.

FI
FI
OS
BBC News
4 sources
Fed Chairman Names Two Outside Advisers During Transitionprnewswire.com
finance44 min ago

Fed Chairman Names Two Outside Advisers During Transition

Federal Reserve Chairman Kevin Warsh appointed two interim advisers shortly after taking the post. One previously contributed to a conservative plan calling for major changes at the central bank.

FI
Wall Street Journal
2 sources
Forte Biosciences Accepts Resignation of Director David Veitchinsidermonkey.com
finance2 hrs agoSourced

Forte Biosciences Accepts Resignation of Director David Veitch

Forte Biosciences disclosed the resignation of independent director David Veitch from its board effective June 1 2026. The departure reduces the company's board size and triggers standard SEC and Nasdaq disclosure obligations for director changes at the clinical-stage biopharmace…

SEC EDGAR — Forte Biosciences, Inc. (FBRX)
1 source